Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
for Familial Hypercholesterolemia - Heterozygous
Drug: Inclisiran
11 locations incl. San Francisco
Sponsor: Novartis Pharmaceuticals
Sex: All·Age: 6 - 11
Code: NCT06597019·Phase 3·Recruiting